Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7049)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2019 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 [PMID: 31885424 DOI: 10.3748/wjg.v25.i47.6835] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i47/6835.htm |
| Number | Citing Articles |
| 1 |
Yanwei Lu, Chenwang Xu, Haitao Wang, Tao Song, Shixiu Wu, Xiaodong Liang, Hong'en Xu. Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.714619
|
| 2 |
Yue Ma, Jie Ren, Zhuo Chen, Jingwen Chen, Ming Wei, Yu Wang, Hong Chen, Liping Wang. Outcomes of intravenous and inhalation anesthesia on patients undergoing esophageal cancer surgery: a retrospective observational study. BMC Anesthesiology 2023; 23(1) doi: 10.1186/s12871-023-02023-1
|
| 3 |
Zhanye Liu, Chunlong Zhao, Shixia Du, Shuangqing Gao, Lijun Lu. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level. Experimental and Molecular Pathology 2020; 115: 104476 doi: 10.1016/j.yexmp.2020.104476
|
| 4 |
Maarten C. C. M. Hulshof, Elisabeth D. Geijsen, Tom Rozema, Vera Oppedijk, Jeroen Buijsen, Karen J. Neelis, Joost J. M. E. Nuyttens, Maurice J. C. van der Sangen, Paul M. Jeene, Jannie G. Reinders, Mark I. van Berge Henegouwen, Adriana Thano, Jeanin E. van Hooft, Hanneke W. M. van Laarhoven, Ate van der Gaast. Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study). Journal of Clinical Oncology 2021; 39(25): 2816 doi: 10.1200/JCO.20.03697
|
| 5 |
Ritu Sarin, Sujatha Peela. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 15 doi: 10.1007/978-981-15-5471-1_2
|
| 6 |
Dong-Xin Hu, Qi-Feng Sun, Lin Xu, Hong-Da Lu, Fan Zhang, Zhen-Miao Li, Ming-Yan Zhang. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma <i>via </i>the PI3K/AKT pathway. World Journal of Gastroenterology 2022; 28(4): 464-478 doi: 10.3748/wjg.v28.i4.464
|
| 7 |
Waqas T Butt, John V Reynolds. Isolated oesophageal adenocarcinoma metastasis at percutaneous endoscopic gastrostomy (PEG) site. BMJ Case Reports 2020; 13(6): e236778 doi: 10.1136/bcr-2020-236778
|
| 8 |
Xi Wu, Ming-Chuang Zhu, Guo-Liang Li, Peng Xiong, Wei Sun, Ni Zhang, Bo Zhao, Le-Qun Li, Xiang-Ning Fu, Min Zhu. Treatment and survival analysis for 40-year SEER data on upper esophageal cancer. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1128766
|
| 9 |
Guangming Liu, Jinying Song, Yong Zhao, Lianjie Zhang, Junjie Qin, Youbin Cui. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway. Journal of Receptors and Signal Transduction 2020; 40(5): 471 doi: 10.1080/10799893.2020.1756327
|
| 10 |
Gui Fu, Zhidong Pei, Nasha Song. Oncogenic microRNA-301b regulates tumor repressor dystrobrevin alpha to facilitate cell growth, invasion and migration in esophageal cancer. Esophagus 2021; 18(2): 315 doi: 10.1007/s10388-020-00764-3
|
| 11 |
J. de Vos-Geelen, S.M.E. Geurts, G.A.P. Nieuwenhuijzen, F.E.M. Voncken, J.A. Bogers, P.M. Braam, C.T. Muijs, M.A. de Jong, N. Kasperts, T. Rozema, G.J. Blom, S.A.W. Bouwense, L.B.J. Valkenburg-van Iersel, P.M. Jeene, F.J.P. Hoebers, V.C.G. Tjan-Heijnen. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer. European Journal of Surgical Oncology 2021; 47(8): 2016 doi: 10.1016/j.ejso.2021.02.001
|
| 12 |
Annelijn E. Slaman, Giovanni Pirozzolo, Wietse J. Eshuis, Jacques J.G.H.M. Bergman, Maarten C.C.M. Hulshof, Hanneke W.M. van Laarhoven, Sybren L. Meijer, Suzanne S. Gisbertz, Mark I. van Berge Henegouwen. Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 Years. The Annals of Thoracic Surgery 2022; 114(4): 1118 doi: 10.1016/j.athoracsur.2022.02.085
|